SIGMA PHARMACEUTICALS LIMITED (SIP)
The operation of a pharmaceutical business encompassing the manufacturing, development and distribution of own branded and contract OTC (over the counter), prescription and generic pharmaceutical products for the Australian and overseas markets.On this page you will find:
|
Delayed share price Company announcements Price history chart Exchange Traded Options |
|
Company details Closing prices Dividends Warrants & Structured Products ASX CFDs |
Delayed share price
Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.
| Code | Last | % Chg | Bid | Offer | Open | High | Low | Vol |
|---|---|---|---|---|---|---|---|---|
| SIP | 0.835 | -1.18% | 0.830 | 0.845 | 0.855 | 0.855 | 0.820 | 1,795,163 |
ASX Find a broker tool
Helps you find an ASX broker based on your needs and where you live.
SIGMA PHARMACEUTICALS LIMITED details
Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.
| Issuer Code | SIP |
|---|---|
| Securities | |
| Official Listing Date | 30 October, 2002 |
| GICS Industry Group | Health Care Equipment & Services |
| Exempt Foreign? | No |
| Internet Address | http://www.sigmaco.com.au/ |
| Registered Office Address | 3 Myer Place, ROWVILLE, VIC, AUSTRALIA, 3178 |
| Head Office Telephone | (03) 9215 9215 |
| Head Office Fax | (03) 9215 9188 |
| Share Registry | LINK MARKET SERVICES LIMITED LEVEL 1, 333 COLLINS STREET, MELBOURNE, VIC, AUSTRALIA, 3000 |
| Share Registry Telephone | 1300 554 474 |
| Directors / Senior Management |
|---|
|
Mr Brian Jamieson (Non Exec. Chairman) Mr Mark Robert Hooper (Managing Director, CEO) Mr David Bayes (Non Exec. Director) Mr Raymond Gunston (Non Exec. Director) Mr David Manuel (Non Exec. Director) Ms Linda Bardo Nicholls (Non Exec. Director) Mr Jeff Sells (CFO) Ms Susan Morgan (General Counsel) Ms Chanmali Tregambe (Investor Relations) |
| Company Secretary |
Ms Susan Morgan |
|---|---|
| Principal Activities | The operation of a pharmaceutical business encompassing the manufacturing, development and distribution of own branded and contract OTC (over the counter), prescription and generic pharmaceutical products for the Australian and overseas markets. |
SIGMA PHARMACEUTICALS LIMITED announcements
How are company announcements published on www.asx.com.au?
| Date | Price sens. |
Headline | Pages | |
|---|---|---|---|---|
| 16/05/2013 | Change in substantial holding | 3 | ||
| 16/05/2013 | Daily share buy-back notice - Appendix 3E | 2 | ||
| 15/05/2013 | Notification of Cancellation of Shares | 5 | ||
| 15/05/2013 | Daily share buy-back notice - Appendix 3E | 2 | ||
| 14/05/2013 | Daily share buy-back notice - Appendix 3E | 2 | ||
| 10/05/2013 | Daily share buy-back notice - Appendix 3E | 2 | ||
| 09/05/2013 | Daily share buy-back notice - Appendix 3E | 2 | ||
| 09/05/2013 | Results of Meeting | 1 | ||
| 08/05/2013 | Sigma 2013 AGM Presentation Slides to Shareholders | 26 | ||
| 08/05/2013 | Chairman Remuneration & Nomination Committee Address to Shar | 2 |
> search for past company announcements
Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.
Closing prices
Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.
| Date | Last | % Change | High | Low | Vol * |
|---|---|---|---|---|---|
| 17 May 2013 | 0.835 | -1.18% | 0.855 | 0.820 | 1,795,163 |
| 16 May 2013 | 0.845 | 1.2% | 0.850 | 0.840 | 4,137,710 |
| 15 May 2013 | 0.835 | 4.37% | 0.840 | 0.805 | 4,055,709 |
| 14 May 2013 | 0.800 | 0% | 0.810 | 0.800 | 1,969,344 |
| 13 May 2013 | 0.800 | 0% | 0.805 | 0.795 | 1,242,190 |
* Volume of shares shown represents only those shares traded on ASX.
SIGMA PHARMACEUTICALS LIMITED price history chart

Dividends
How are dividends released on www.asx.com.au?
| Code | Div Amount | Ex Div Date | Record Date | Date Payable | % Franked | Type | Further Information |
|---|---|---|---|---|---|---|---|
| SIP | 2c | 21/09/2012 | 27/09/2012 | 26/10/2012 | 100% | Interim | 2C FRANKED @ 30% D.R.P. SUSPENDED |
| SIP | 2c | 19/03/2013 | 25/03/2013 | 19/04/2013 | 100% | Final | 2C FRANKED @ 30% D.R.P. SUSPENDED |
Exchange Traded Options
No Exchange Traded Options are available over the security SIP
Warrants & Structured Products
No warrants & Structured Products are available over the security SIP
ASX CFDs
No Contracts For Differences are available over the security SIP

